These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18586363)

  • 41. Immunogenicity of anthrax recombinant peptides and killed spores in goats and protective efficacy of immune sera in A/J mouse model.
    Ndumnego OC; Koehler SM; Crafford JE; Beyer W; van Heerden H
    Sci Rep; 2018 Nov; 8(1):16937. PubMed ID: 30446695
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The anthrax vaccine: no new tricks for an old dog.
    Bienek DR; Loomis LJ; Biagini RE
    Hum Vaccin; 2009 Mar; 5(3):184-9. PubMed ID: 19270504
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of recombinant anthrax vaccine against Bacillus anthracis aerosol spore challenge: preclinical evaluation in rabbits and Rhesus monkeys.
    Chawla A; Midha S; Bhatnagar R
    Biotechnol J; 2009 Mar; 4(3):391-9. PubMed ID: 19296443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low doses of antigen coupled to anti-CR2 mAbs induce rapid and enduring IgG immune responses in mice and in cynomolgus monkeys.
    Whipple EC; Ditto AH; Shanahan RS; Gatesman JJ; Little SF; Taylor RP; Lindorfer MA
    Mol Immunol; 2007 Jan; 44(4):377-88. PubMed ID: 16631928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A two-stage, multilevel quality control system for serological assays in anthrax vaccine clinical trials.
    Soroka SD; Schiffer JM; Semenova VA; Li H; Foster L; Quinn CP
    Biologicals; 2010 Nov; 38(6):675-83. PubMed ID: 20875951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vaccines: countering anthrax: vaccines and immunoglobulins.
    Grabenstein JD
    Clin Infect Dis; 2008 Jan; 46(1):129-36. PubMed ID: 18171228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gorse GJ, et al. "Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial" [Vaccine 24 (2006) 5950-5959].
    Zink TK
    Vaccine; 2007 Apr; 25(15):2766-7. PubMed ID: 17224206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunological dynamics in response to two anthrax vaccines in mice.
    Lü J; He R; Dong M; Zhang L; Wang X
    Sci China C Life Sci; 2008 Oct; 51(10):872-8. PubMed ID: 18815750
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of immunogenicity and efficacy of anthrax vaccine adsorbed for postexposure prophylaxis.
    Ionin B; Hopkins RJ; Pleune B; Sivko GS; Reid FM; Clement KH; Rudge TL; Stark GV; Innes A; Sari S; Guina T; Howard C; Smith J; Swoboda ML; Vert-Wong E; Johnson V; Nabors GS; Skiadopoulos MH
    Clin Vaccine Immunol; 2013 Jul; 20(7):1016-26. PubMed ID: 23658392
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of immune response to orally administered Sterne strain 34F2 anthrax vaccine.
    Shakya KP; Hugh-Jones ME; Elzer PH
    Vaccine; 2007 Jul; 25(29):5374-7. PubMed ID: 17555849
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protective activity and immunogenicity of two recombinant anthrax vaccines for veterinary use.
    Fasanella A; Tonello F; Garofolo G; Muraro L; Carattoli A; Adone R; Montecucco C
    Vaccine; 2008 Oct; 26(45):5684-8. PubMed ID: 18775462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibody response to a delayed booster dose of anthrax vaccine and botulinum toxoid.
    Pittman PR; Hack D; Mangiafico J; Gibbs P; McKee KT; Friedlander AM; Sjogren MH
    Vaccine; 2002 May; 20(16):2107-15. PubMed ID: 11972980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anthrax vaccine efficacy in golden Syrian hamsters.
    Fellows PF; Linscott MK; Little SF; Gibbs P; Ivins BE
    Vaccine; 2002 Jan; 20(9-10):1421-4. PubMed ID: 11818161
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced vaccine antigen delivery by Salmonella using antibiotic-free operator-repressor titration-based plasmid stabilisation compared to chromosomal integration.
    Leckenby MW; Spear AM; Neeson BN; Williamson ED; Cranenburgh RM; Atkins HS
    Microb Pathog; 2009 Apr; 46(4):201-6. PubMed ID: 19490834
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Results of a safety and immunogenicity study of an early-stage investigational rPA102 vaccine as compared to the FDA licensed anthrax vaccine (anthrax vaccine adsorbed (AVA. BioThrax)).
    Hannesschlager JR
    Vaccine; 2007 Apr; 25(17):3247. PubMed ID: 17234308
    [No Abstract]   [Full Text] [Related]  

  • 56. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system.
    Crotty S; Aubert RD; Glidewell J; Ahmed R
    J Immunol Methods; 2004 Mar; 286(1-2):111-22. PubMed ID: 15087226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic immunization with GPI-anchored anthrax protective antigen raises combined CD1d- and MHC II-restricted antibody responses by natural killer T cell-mediated help.
    Midha S; Bhatnagar R
    Vaccine; 2009 Mar; 27(11):1700-9. PubMed ID: 19195490
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potential biological targets of Bacillus anthracis in anti-infective approaches against the threat of bioterrorism.
    Bouzianas DG
    Expert Rev Anti Infect Ther; 2007 Aug; 5(4):665-84. PubMed ID: 17678429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Feasibility of the use of ELISA in an immunogenicity-based potency test of anthrax vaccines.
    Jiménez-Alberto A; Parreiras P; Castelán-Vega J; Sirota L; Arciniega J
    Biologicals; 2011 Jul; 39(4):236-41. PubMed ID: 21664832
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial.
    Pondo T; Rose CE; Martin SW; Keitel WA; Keyserling HL; Babcock J; Parker S; Jacobson RM; Poland GA; McNeil MM
    Vaccine; 2014 Jun; 32(28):3548-54. PubMed ID: 24768633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.